Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John Bridgeman
23 Görünümler
• 07/30/23
0
0
gömmek
administrator
Aboneler
A look at the use of TIL in Melanoma and future TIL engineering strategies. John Bridgeman is the Director of Cell Therapy Research at Immetacyte Ltd
Daha fazla göster
Facebook Yorumları
SORT BY-
En Çok Yorumlananlar
-
Son Yorumlar